LFST on Nasdaq
LifeStance Health Group, Inc.
American health services company, incorporated in Delaware. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with P3 Health Partners Inc., InnovAge Holding Corp. or Privia Health Group, Inc., or pick any stock.
- TickerLFST on Nasdaq1
- IndustryServices-Health Services1
- HeadquartersScottsdale, Arizona1
- Incorporated inDE2
- Business address4800 N. Scottsdale Road, Suite 2500, Scottsdale, Az 852512
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
Unless stated otherwise or the context otherwise requires, the terms "we," "us," "our," "our business," "LifeStance" and "our Company" and similar references refer to LifeStance Health Group, Inc. and its consolidated subsidiaries and supported practices. References to "our employees" and "our clinicians" refer collectively to employees and clinicians, respectively, of our subsidiaries and supported practices. References to "our patients" refer to the patients treated by such clinicians.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
1.7%Operating margin4
0.7%Net margin4
13.9%Revenue growth, 20254
0.6%Return on equity4
0.17×Debt to equity4
$110.0MFree cash flow4
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Selling, general and admin27¢$382.2M
- Other costs71¢$1.0B
- Interest1¢$11.7M
- Income tax0¢$2.7M
- Profit1¢$9.7M
Out of $1.4B in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending25¢$36.1M
- Kept or used elsewhere75¢$110.0M
Out of $146.2M of cash from operations.4
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| TOTAL REVENUE | $1.4B | $1.3B | $1.1B |
| Center costs, excluding depreciation and amortization shown separately below | $963.2M | $848.6M | $753.6M |
| General and administrative expenses | $382.2M | $363.1M | $410.8M |
| Depreciation and amortization | $54.8M | $71.0M | $80.4M |
| Total operating expenses | $1.4B | $1.3B | $1.2B |
| INCOME (LOSS) FROM OPERATIONS | $24.1M | -$31.6M | -$189.1M |
| Gain on remeasurement of contingent consideration | $0 | $1.7M | $4.0M |
| Transaction costs | $0 | -$827.0K | -$89.0K |
| Interest expense, net | -$11.7M | -$26.5M | -$21.2M |
| Other expense | -$123.0K | -$363.0K | -$112.0K |
| Total other expense | -$11.8M | -$26.0M | -$17.4M |
| INCOME (LOSS) BEFORE INCOME TAXES | $12.4M | -$57.6M | -$206.6M |
| INCOME TAX (PROVISION) BENEFIT | -$2.7M | $170.0K | $20.3M |
| NET INCOME (LOSS) | $9.7M | -$57.4M | -$186.3M |
| EARNINGS (LOSS) PER SHARE, Basic | $0 | -$0 | -$1 |
| EARNINGS (LOSS) PER SHARE, Diluted | $0 | -$0 | -$1 |
| Weighted-average shares outstanding - Basic | 386.0M shares | 379.1M shares | 367.5M shares |
| Weighted-average shares outstanding - Diluted | 391.1M shares | 379.1M shares | 367.5M shares |
| Unrealized losses on cash flow hedge, net of tax | -$929.0K | -$1.4M | -$971.0K |
| COMPREHENSIVE INCOME (LOSS) | $8.7M | -$58.8M | -$187.2M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 2 fiscal years (annual) or 2 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash and cash equivalents | $248.6M | $154.6M |
| Patient accounts receivable, net | $95.7M | $131.8M |
| Prepaid expenses and other current assets | $71.8M | $26.1M |
| Total current assets | $416.2M | $312.5M |
| Property and equipment, net | $161.6M | $166.0M |
| Right-of-use assets | $149.7M | $147.9M |
| Intangible assets, net | $177.7M | $190.8M |
| Goodwill | $1.3B | $1.3B |
| Other noncurrent assets | $5.4M | $7.7M |
| Total noncurrent assets | $1.8B | $1.8B |
| Total assets | $2.2B | $2.1B |
| Accounts payable | $6.1M | $7.2M |
| Accrued payroll expenses | $143.3M | $117.5M |
| Other accrued expenses | $42.2M | $46.9M |
| Operating lease liabilities, current | $45.5M | $49.4M |
| Other current liabilities | $14.8M | $7.8M |
| Total current liabilities | $252.0M | $228.9M |
| Long-term debt, net | $265.9M | $279.8M |
| Operating lease liabilities, noncurrent | $148.6M | $148.7M |
| Deferred tax liability, net | $16.4M | $14.3M |
| Other noncurrent liabilities | $68.0K | $309.0K |
| Total noncurrent liabilities | $431.0M | $443.1M |
| Total liabilities | $682.9M | $672.0M |
| Preferred stock - par value $0.01 per share; 25,000 shares authorized as of December 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | $0 | $0 |
| Common stock - par value $0.01 per share; 800,000 shares authorized as of December 31, 2025 and December 31, 2024; 388,318 and 382,735 shares issued and outstanding as of December 31, 2025 and December 31, 2024 ,respectively | $3.9M | $3.8M |
| Additional paid-in capital | $2.3B | $2.3B |
| Accumulated other comprehensive income | $0 | $929.0K |
| Accumulated deficit | -$808.6M | -$818.3M |
| Total stockholders' equity | $1.5B | $1.4B |
| Total liabilities and stockholders' equity | $2.2B | $2.1B |
| Preferred Stock, par value | $0.01 | $0.01 |
| Preferred Stock, Shares Authorized | 25.0M shares | 25.0M shares |
| Preferred Stock, Shares Issued | 0 shares | 0 shares |
| Preferred Stock, Shares Outstanding | 0 shares | 0 shares |
| Common Stock, par value | $0.01 | $0.01 |
| Common Stock, Shares Authorized | 800.0M shares | 800.0M shares |
| Common Stock, Shares, Issued | 388.3M shares | 382.7M shares |
| Common Stock, Shares, Outstanding | 388.3M shares | 382.7M shares |
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash and cash equivalents | $248.6M | $154.6M |
| Patient accounts receivable, net | $95.7M | $131.8M |
| Prepaid expenses and other current assets | $71.8M | $26.1M |
| Total current assets | $416.2M | $312.5M |
| Property and equipment, net | $161.6M | $166.0M |
| Right-of-use assets | $149.7M | $147.9M |
| Intangible assets, net | $177.7M | $190.8M |
| Goodwill | $1.3B | $1.3B |
| Other noncurrent assets | $5.4M | $7.7M |
| Total noncurrent assets | $1.8B | $1.8B |
| Total assets | $2.2B | $2.1B |
| Accounts payable | $6.1M | $7.2M |
| Accrued payroll expenses | $143.3M | $117.5M |
| Other accrued expenses | $42.2M | $46.9M |
| Operating lease liabilities, current | $45.5M | $49.4M |
| Other current liabilities | $14.8M | $7.8M |
| Total current liabilities | $252.0M | $228.9M |
| Long-term debt, net | $265.9M | $279.8M |
| Operating lease liabilities, noncurrent | $148.6M | $148.7M |
| Deferred tax liability, net | $16.4M | $14.3M |
| Other noncurrent liabilities | $68.0K | $309.0K |
| Total noncurrent liabilities | $431.0M | $443.1M |
| Total liabilities | $682.9M | $672.0M |
| Preferred stock - par value $0.01 per share; 25,000 shares authorized as of December 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | $0 | $0 |
| Common stock - par value $0.01 per share; 800,000 shares authorized as of December 31, 2025 and December 31, 2024; 388,318 and 382,735 shares issued and outstanding as of December 31, 2025 and December 31, 2024 ,respectively | $3.9M | $3.8M |
| Additional paid-in capital | $2.3B | $2.3B |
| Accumulated other comprehensive income | $0 | $929.0K |
| Accumulated deficit | -$808.6M | -$818.3M |
| Total stockholders' equity | $1.5B | $1.4B |
| Total liabilities and stockholders' equity | $2.2B | $2.1B |
| Preferred Stock, par value | $0.01 | $0.01 |
| Preferred Stock, Shares Authorized | 25.0M shares | 25.0M shares |
| Preferred Stock, Shares Issued | 0 shares | 0 shares |
| Preferred Stock, Shares Outstanding | 0 shares | 0 shares |
| Common Stock, par value | $0.01 | $0.01 |
| Common Stock, Shares Authorized | 800.0M shares | 800.0M shares |
| Common Stock, Shares, Issued | 388.3M shares | 382.7M shares |
| Common Stock, Shares, Outstanding | 388.3M shares | 382.7M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | $9.7M | -$57.4M | -$186.3M |
| Depreciation and amortization | $54.8M | $71.0M | $80.4M |
| Non-cash operating lease costs | $41.9M | $39.5M | $40.0M |
| Stock-based compensation | $74.7M | $76.2M | $99.4M |
| Deferred income taxes | $2.4M | -$958.0K | -$21.9M |
| Loss on debt extinguishment | $0 | $5.0M | $0 |
| Amortization of discount and debt issue costs | $1.0M | $1.7M | $2.1M |
| Gain on remeasurement of contingent consideration | $0 | -$1.7M | -$4.0M |
| Other, net | $2.0M | $1.4M | $7.1M |
| Patient accounts receivable, net | $36.1M | -$6.4M | -$24.2M |
| Prepaid expenses and other current assets | -$46.7M | -$3.3M | -$3.1M |
| Accounts payable | -$1.6M | $501.0K | -$5.6M |
| Accrued payroll expenses | $25.9M | $15.0M | $26.5M |
| Operating lease liabilities | -$48.1M | -$46.7M | -$37.6M |
| Other accrued expenses | -$5.9M | $13.6M | $10.2M |
| Net cash provided by (used in) operating activities | $146.2M | $107.3M | -$16.9M |
| Purchases of property and equipment | -$36.1M | -$21.6M | -$40.5M |
| Acquisitions of businesses, net of cash acquired | $0 | $0 | -$19.8M |
| Net cash used in investing activities | -$36.1M | -$21.6M | -$60.3M |
| Proceeds from long-term debt, net of discount | $0 | $287.8M | $57.8M |
| Payments of debt issue costs | $0 | -$1.8M | -$188.0K |
| Payments of long-term debt | -$7.2M | -$289.5M | -$2.5M |
| Payments of contingent consideration | $0 | -$6.4M | -$7.7M |
| Taxes related to net share settlement of equity awards | -$8.7M | $0 | $0 |
| Net cash (used in) provided by financing activities | -$16.0M | -$9.9M | $47.4M |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | $94.1M | $75.7M | -$29.8M |
| Cash paid for interest, net | $17.8M | $25.0M | $21.0M |
| Cash paid for taxes, net of refunds | $1.6M | $57.0K | $80.0K |
| Contingent consideration incurred in acquisitions of businesses | $0 | $0 | $2.0M |
| Acquisition of property and equipment included in liabilities | $2.9M | $1.5M | $3.8M |
No quarter-by-quarter statement was filed.
Leadership
Who has led LifeStance Health Group, Inc., and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
Chief operating officer
2025
- Chief executive officerDavid Bourdon Mar 10, 2025 to now11
- Chief executive officerKen Burdick Sep 9, 2022 to Mar 19, 202412
- Chief executive officerMichael K. Lester Jun 11, 2021 to Jun 14, 202213
- PresidentMichael K. Lester Jun 11, 2021 to Jun 14, 202213
- Chief financial officerDavid Bourdon Nov 14, 2022 to Mar 12, 202414
- Chief financial officerJesse Michael Bruff Jun 10, 2021 to Apr 26, 202215
- Chief operating officerGwen H. Booth Jun 10, 2021 to Jun 14, 202216
Board members and other officers (28)
- Chief Medical OfficerStephanie Carin Eken Feb 24, 2026 to now17
- OfficerRyan McGroarty Mar 18, 2025 to now18
- Chief Technology OfficerVukasin Paunovich Jun 13, 2025 to now19
- Chief Medical OfficerUjjwal Ramtekkar Jan 25, 2024 to now20
- Chief People OfficerAnn Varanakis Feb 13, 2023 to now21
- OfficerPaula Cipollone Sep 27, 2023 to May 14, 202422
- Chief Medical OfficerAnisha Patel-Dunn Jun 10, 2021 to Jun 29, 202323
- Chief Growth OfficerDanish J. Qureshi Jun 10, 2021 to Jun 18, 202424
- Chief People OfficerFelicia Gorcyca Jun 10, 2021 to Jun 14, 202225
- OfficerMichael K. Lester Jun 10, 2021 to Jun 10, 202126
- Chief Digital OfficerPablo Pantaleoni Jun 10, 2021 to now27
- OfficerRyan Pardo Jun 10, 2021 to now28
- Chief Administrative OfficerWarren Gouk Jun 10, 2021 to Sep 5, 202329
- Board memberRyan Pardo Mar 11, 2026 to now30
- Board memberLori Goltermann Jul 7, 2026 to now31
- Board memberSafwan Shabab Jul 7, 2026 to now32
- Board memberThurman Justice Jul 7, 2026 to now33
- Board memberDavid Bourdon Mar 10, 2025 to now11
- Board memberEric P. Palmer Jun 13, 2025 to now34
- Board memberSarah Personette Oct 28, 2025 to now35
- Board memberTeresa Deluca Mar 18, 2024 to now36
- Board memberKen Burdick Sep 9, 2022 to now12
- Board memberDarren M. Black Jun 10, 2021 to now37
- Board memberEric Shuey Jun 10, 2021 to now38
- Board memberCrisan Jeffrey Jun 10, 2021 to May 29, 202439
- Board memberJeffrey K. Rhodes Jun 10, 2021 to Jun 10, 202140
- Board memberMichael K. Lester Jun 10, 2021 to Jun 14, 202226
- Board memberRobert Bessler Jun 10, 2021 to now41
Timeline
Filings
427 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 42 major events, 226 insider forms, 26 large holders, 113 other. The latest 20:
- Oct 5, 2026SCHEDULE 13G/A EDGAR
- Sep 24, 20264 EDGAR
- Sep 15, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
- Sep 11, 20268-K EDGAR
- Sep 10, 2026424B7 EDGAR
- Sep 9, 2026424B7 EDGAR
- Sep 4, 20264 EDGAR
- Sep 4, 20264 EDGAR
- Sep 2, 2026144 EDGAR
- Aug 26, 20264 EDGAR
- Aug 18, 20264 EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 14, 2026144 EDGAR
- Aug 14, 20264 EDGAR
- Aug 13, 2026144 EDGAR
- Aug 13, 20264 EDGAR
- Aug 12, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP EDGAR
- Aug 12, 20264 EDGAR
- Aug 12, 20264 EDGAR
- Aug 11, 2026144 EDGAR
The 427 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
125 open-market trades by officers, directors and large owners since October 2021: 2 buys and 123 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | TPG GP A, LLC10% owner | Sale | 18,409,705 | $12.29 | $226.3M | Form 4 |
| Sep 2, 2026 | Paunovich VukasinChief Technology Officer | Sale | 42,067 | $12.87 | $541.4K | Form 4 |
| Aug 14, 2026 | DeLuca TeresaDirector | Sale | 7,500 | $12.68 | $95.1K | Form 4 |
| Aug 13, 2026 | DeLuca TeresaDirector | Sale | 20,441 | $12.23 | $250.0K | Form 4 |
| Aug 11, 2026 | Burdick Kenneth ADirector | Sale | 500,000 | $11.51 | $5.8M | Form 4 |
| Aug 10, 2026 | TPG GP A, LLC10% owner | Sale | 13,643,207 | $10.62 | $144.9M | Form 4 |
| Aug 10, 2026 | Paunovich VukasinChief Technology Officer | Sale | 44,394 | $10.85 | $481.7K | Form 4 |
| Aug 10, 2026 | Miller Lisa KChief Operating Officer | Sale | 47,912 | $10.85 | $519.8K | Form 4 |
| Jun 26, 2026 | Bessler RobertDirector | Sale | 894,337 | $10.13 | $9.1M | Form 4 |
| May 12, 2026 | TPG GP A, LLC10% owner | Sale | 28,281,943 | $8.02 | $226.8M | Form 4 |
| May 12, 2026 | Bessler RobertDirector | Sale | 575,034 | $8.02 | $4.6M | Form 4 |
| May 12, 2026 | Shuey EricDirector | Sale | 243,362 | $8.02 | $2.0M | Form 4 |
| May 12, 2026 | BLACK DARREN M.Director | Sale | 5,899,661 | $8.02 | $47.3M | Form 4 |
| May 7, 2026 | Bessler RobertDirector | Sale | 75,000 | $8.55 | $641.2K | Form 4 |
| Apr 24, 2026 | Bessler RobertDirector | Sale | 62,147 | $7.05 | $438.1K | Form 4 |
| Apr 23, 2026 | Bessler RobertDirector | Sale | 7,752 | $7.00 | $54.3K | Form 4 |
| Apr 21, 2026 | Bessler RobertDirector | Sale | 5,101 | $7.01 | $35.8K | Form 4 |
| Mar 2, 2026 | TPG GP A, LLC10% owner | Sale | 20,685,061 | $7.01 | $145.0M | Form 4 |
| Mar 2, 2026 | BLACK DARREN M.Director | Sale | 4,314,939 | $7.01 | $30.2M | Form 4 |
| Dec 22, 2025 | Bessler RobertDirector | Sale | 1,701 | $7.04 | $12.0K | Form 4 |
All 125 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G/A, 2 filings Jul 29, 2026 to Oct 5, 202642
- TPG GP A, LLCSCHEDULE 13G/A, 4 filings Feb 11, 2022 to Aug 14, 202643
- SUMMIT PARTNERS L PSCHEDULE 13G/A, 5 filings Feb 4, 2022 to Aug 11, 202644
- FMR LLCSCHEDULE 13G/A, 10 filings Feb 9, 2022 to May 6, 202645
- Silversmith Partners I GP, LLCSC 13G/A, 2 filings Feb 14, 2022 to Nov 14, 202446
- Michael K. LesterSC 13G/A, 3 filings Feb 18, 2022 to Jan 24, 202447
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Tpg Gp A, LLC | 111,744,614 | $1.2B | 23.9% | −28,281,943 |
| Fmr LLC | 58,252,466 | $623.9M | 0.0% | −433,014 |
| BlackRock, Inc. | 36,348,507 | $389.3M | 0.0% | +18,213,556 |
| Summit Partners L P | 23,310,115 | $249.7M | 41.0% | −5,899,661 |
| Vanguard Portfolio Management LLC | 13,960,892 | $149.5M | 0.0% | +4,278,587 |
| Jennison Associates LLC | 12,077,557 | $129.4M | 0.1% | +1,848,756 |
| Dimensional Fund Advisors LP | 11,427,602 | $122.4M | 0.0% | +1,059,922 |
| Vanguard Capital Management LLC | 9,735,076 | $104.3M | 0.0% | +1,826,917 |
| State Street Corp | 8,228,351 | $88.1M | 0.0% | +4,134,857 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5,947,600 | $63.7M | 0.0% | −144,623 |
| Geode Capital Management, LLC | 5,592,598 | $59.9M | 0.0% | +867,444 |
| Morgan Stanley | 5,021,527 | $53.8M | 0.0% | +1,580,301 |
| Principal Financial Group Inc | 3,996,866 | $42.8M | 0.0% | +919,211 |
| Millennium Management LLC | 3,606,755 | $38.6M | 0.0% | +1,707,706 |
| First Eagle Investment Management, LLC | 3,125,932 | $33.5M | 0.0% | +1,515,466 |
| Nuveen, LLC | 3,061,724 | $32.8M | 0.0% | +850,792 |
| Integral Health Asset Management, LLC | 3,000,000 | $32.1M | 1.3% | −1,300,000 |
| Wellington Management Group Llp | 2,883,371 | $30.9M | 0.0% | New |
| Northern Trust Corp | 2,137,906 | $22.9M | 0.0% | +603,053 |
| Woodline Partners LP | 2,068,445 | $22.2M | 0.1% | +253,224 |
| Barclays PLC | 2,054,414 | $22.0M | 0.0% | −711,278 |
| Charles Schwab Investment Management Inc | 1,979,078 | $21.2M | 0.0% | +436,973 |
| Mackenzie Financial Corp | 1,967,647 | $21.1M | 0.0% | New |
| Loomis Sayles & Co L P | 1,882,750 | $20.2M | 0.0% | +200,419 |
| Goldman Sachs Group Inc | 1,811,778 | $19.4M | 0.0% | −274,665 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARKen Burdick, Chief executive officer
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARRyan McGroarty, Officer
- 19
- 20
- 21SEC EDGARAnn Varanakis, Chief People Officer
- 22SEC EDGARPaula Cipollone, Officer
- 23
- 24
- 25
- 26SEC EDGARMichael K. Lester, Officer
- 27
- 28SEC EDGARRyan Pardo, Officer
- 29
- 30SEC EDGARRyan Pardo, Board member
- 31SEC EDGARLori Goltermann, Board member
- 32SEC EDGARSafwan Shabab, Board member
- 33SEC EDGARThurman Justice, Board member
- 34SEC EDGAREric P. Palmer, Board member
- 35SEC EDGARSarah Personette, Board member
- 36SEC EDGARTeresa Deluca, Board member
- 37SEC EDGARDarren M. Black, Board member
- 38SEC EDGAREric Shuey, Board member
- 39SEC EDGARCrisan Jeffrey, Board member
- 40SEC EDGARJeffrey K. Rhodes, Board member
- 41SEC EDGARRobert Bessler, Board member
- 42
- 43
- 44
- 45
- 46
- 47